Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | carbonic anhydrase I | Starlite/ChEMBL | References |
Homo sapiens | carbonic anhydrase IX | Starlite/ChEMBL | References |
Homo sapiens | carbonic anhydrase XII | Starlite/ChEMBL | References |
Homo sapiens | carbonic anhydrase II | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | carbonic anhydrase-like protein | carbonic anhydrase I | 261 aa | 281 aa | 25.3 % |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | carbonic anhydrase II | 260 aa | 259 aa | 32.0 % |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | carbonic anhydrase XII | 354 aa | 295 aa | 23.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Transglutaminase/protease, putative | 0.0958 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0958 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0958 | 0.5 | 0.5 |
Echinococcus granulosus | Transglutaminase | 0.0958 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0958 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0958 | 0.5 | 0.5 | |
Mycobacterium ulcerans | hypothetical protein | 0.0958 | 0.5 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0958 | 0.5 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0958 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0958 | 0.5 | 0.5 |
Mycobacterium ulcerans | putative transglutaminase-like protein | 0.0958 | 0.5 | 0.5 |
Trichomonas vaginalis | peptide N-glycanase, putative | 0.0958 | 0.5 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0958 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Long conserved protein | 0.0958 | 0.5 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0958 | 0.5 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0958 | 0.5 | 0.5 |
Mycobacterium ulcerans | transglutaminase family protein | 0.0958 | 0.5 | 0.5 |
Echinococcus multilocularis | Transglutaminase | 0.0958 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 2 nM | Inhibition of human carbonic anhydrase 9-mediated CO2 hydration preincubated for 10 mins by stopped-flow assay | ChEMBL. | 24589484 |
Ki (binding) | = 9.2 nM | Inhibition of human carbonic anhydrase 2-mediated CO2 hydration preincubated for 10 mins by stopped-flow assay | ChEMBL. | 24589484 |
Ki (binding) | = 9.6 nM | Inhibition of human carbonic anhydrase 1-mediated CO2 hydration preincubated for 10 mins by stopped-flow assay | ChEMBL. | 24589484 |
Ki (binding) | = 10.4 nM | Inhibition of human carbonic anhydrase 12-mediated CO2 hydration preincubated for 10 mins by stopped-flow assay | ChEMBL. | 24589484 |
Ratio Ki (binding) | = 12 | Ratio of acetazolamide Ki to compound Ki for human carbonic anhydrase 9 | ChEMBL. | 24589484 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.